Virtus Investment Advisers, Inc. Axonics, Inc. Transaction History

Virtus Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$49.38 - $63.75 $62,811 - $81,090	-1,272 Reduced 53.65%	1,099 $68,000
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $252,907 - $317,306	-5,270 Reduced 68.97%	2,371 $119,000
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $9,362 - $11,986	178 Added 2.39%	7,641 $416,000
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $432,555 - $583,009	7,463 New	7,463 $526,000

221

42M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.